These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 26721936)

  • 21. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort.
    Vavricka SR; Brun L; Ballabeni P; Pittet V; Prinz Vavricka BM; Zeitz J; Rogler G; Schoepfer AM
    Am J Gastroenterol; 2011 Jan; 106(1):110-9. PubMed ID: 20808297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients.
    Yang BR; Choi NK; Kim MS; Chun J; Joo SH; Kim H; Lee J
    PLoS One; 2018; 13(7):e0200363. PubMed ID: 29990326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Prevalence of Ocular Extra-Intestinal Manifestations in Adults Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Li JX; Chiang CC; Chen SN; Lin JM; Tsai YY
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients.
    Roth R; Vavricka S; Scharl M; Schreiner P; Safroneeva E; Greuter T; Zeitz J; Misselwitz B; Schoepfer A; Barry MP; Rogler G; Biedermann L;
    United European Gastroenterol J; 2021 Sep; 9(7):773-780. PubMed ID: 34431613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease.
    Vegh Z; Kurti Z; Gonczi L; Golovics PA; Lovasz BD; Szita I; Balogh M; Pandur T; Vavricka SR; Rogler G; Lakatos L; Lakatos PL
    Scand J Gastroenterol; 2016 Jul; 51(7):848-54. PubMed ID: 26880133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and characteristics of ophthalmological extra-intestinal manifestations in Chinese patients with inflammatory bowel disease.
    Li YC; Li WZ; Wu CR; Feng Y; Ren L; Mi C; Li Y
    Int J Ophthalmol; 2016; 9(10):1476-1479. PubMed ID: 27803867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease.
    Khrom M; Long M; Dube S; Robbins L; Botwin GJ; Yang S; Mengesha E; Li D; Naito T; Bonthala NN; Ha C; Melmed G; Rabizadeh S; Syal G; Vasiliauskas E; Ziring D; Brant SR; Cho J; Duerr RH; Rioux J; Schumm P; Silverberg M; Ananthakrishnan AN; Faubion WA; Jabri B; Lira SA; Newberry RD; Sandler RS; Xavier RJ; Kugathasan S; Hercules D; Targan SR; Sartor RB; Haritunians T; McGovern DPB
    Gastroenterology; 2024 Jul; 167(2):315-332. PubMed ID: 38490347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucocutaneous manifestations in patients with inflammatory bowel disease: a decade study from a Greek cohort.
    Koumaki D; Machaira A; Katoulis AC; Bitados P; Orfanoudaki E; Foteinogiannopoulou K; Stefanidou M; Krasagakis K; Koutroubakis IE
    Eur J Gastroenterol Hepatol; 2021 Nov; 33(11):1387-1393. PubMed ID: 33470697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucocutaneous manifestations in inflammatory bowel disease.
    Yüksel I; Başar O; Ataseven H; Ertuğrul I; Arhan M; Ibiş M; Dağli U; Demirel BT; Ulker A; Seçilmiş S; Saşmaz N
    Inflamm Bowel Dis; 2009 Apr; 15(4):546-50. PubMed ID: 19023896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What are the risk factors for extraintestinal manifestations in inflammatory bowel diseases?
    Yeo MK; Park JH; Kang SH; Moon HS; Sung JK; Jeong HY; Kim JS
    Medicine (Baltimore); 2023 Mar; 102(9):e33031. PubMed ID: 36862909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ophthalmic manifestations in patients with inflammatory bowel disease: A review.
    Troncoso LL; Biancardi AL; de Moraes HV; Zaltman C
    World J Gastroenterol; 2017 Aug; 23(32):5836-5848. PubMed ID: 28932076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sex-Related Differences in Patients With Inflammatory Bowel Disease: Results of 2 Prospective Cohort Studies.
    Severs M; Spekhorst LM; Mangen MJ; Dijkstra G; Löwenberg M; Hoentjen F; van der Meulen-de Jong AE; Pierik M; Ponsioen CY; Bouma G; van der Woude JC; van der Valk ME; Romberg-Camps MJL; Clemens CHM; van de Meeberg P; Mahmmod N; Jansen J; Jharap B; Weersma RK; Oldenburg B; Festen EAM; Fidder HH
    Inflamm Bowel Dis; 2018 May; 24(6):1298-1306. PubMed ID: 29688413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of and Factors Associated With Extraintestinal Manifestations and Their Remission in Inflammatory Bowel Disease: The EXTRA-Intestinal Manifestation Prospective Study From the Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif.
    Guillo L; Savoye G; Amiot A; Gilletta C; Nachury M; Dib N; Bourreille A; Roblin X; Caillo L; Allez M; Picon L; Hébuterne X; Seksik P; Chupin A; Buisson A; Brixi H; Altwegg R; Simon M; Amil M; Laharie D; Bouguen G; Serrero M; Elgharabawy Y; Peyrin-Biroulet L;
    Clin Transl Gastroenterol; 2023 Dec; 14(12):e00607. PubMed ID: 37523417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extraintestinal manifestation of inflammatory bowel disease in Asian patients: A multinational study.
    Park SK; Wong Z; Park SH; Vu KV; Bang KB; Piyachaturawat P; Myint T; Hilmi I; Park DI
    Dig Liver Dis; 2021 Feb; 53(2):196-201. PubMed ID: 32736897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk Factors for Extraintestinal Manifestations in Inflammatory Bowel Diseases - Data from the Romanian National Registry.
    Singeap AM; Girleanu I; Diculescu M; Gheorghe L; Ciocîrlan M; Gheorghe C; Costache A; Tanțău A; Zaharie R; Goldis A; Gheonea D; Dobru D; Dumitru E; Prelipcean CC; Gîlcă-Blanariu GE; Moscalu M; Stanciu C; Trifan A
    J Gastrointestin Liver Dis; 2021 Sep; 30(3):346-357. PubMed ID: 34375380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.
    Roth N; Biedermann L; Fournier N; Butter M; Vavricka SR; Navarini AA; Rogler G; Scharl M;
    PLoS One; 2019; 14(1):e0210436. PubMed ID: 30682031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extraintestinal Manifestations of Inflammatory Bowel Disease in Middle Eastern Patients.
    Adam H; Alqassas M; Saadah OI; Mosli M
    J Epidemiol Glob Health; 2020 Dec; 10(4):298-303. PubMed ID: 32959603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry.
    Algaba A; Guerra I; Ricart E; Iglesias E; Mañosa M; Gisbert JP; Guardiola J; Mínguez M; Castro B; de Francisco R; Nos P; Bertoletti F; Mesonero F; Barrio J; Martín-Arranz MD; Calvet X; García-López S; Sicilia B; Alcaín G; Esteve M; Márquez L; Piqueras M; Jiménez L; Perez-Calle JL; Bujanda L; García-Sepulcre M; Fernández A; Moraleja I; Lorente RH; García-Bosch O; Lambán A; Blázquez I; Rodríguez E; Huguet JM; Lucendo AJ; Almela P; Busquets D; Ramírez de la Piscina P; Pérez M; Domenech E; Bermejo F;
    Dig Dis Sci; 2021 Jun; 66(6):2014-2023. PubMed ID: 32671587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Kilic Y; Kamal S; Jaffar F; Sriranganathan D; Quraishi MN; Segal JP
    Inflamm Bowel Dis; 2024 Feb; 30(2):230-239. PubMed ID: 37042969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease.
    Jose FA; Garnett EA; Vittinghoff E; Ferry GD; Winter HS; Baldassano RN; Kirschner BS; Cohen SA; Gold BD; Abramson O; Heyman MB
    Inflamm Bowel Dis; 2009 Jan; 15(1):63-8. PubMed ID: 18626963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.